About Claritev Corporation
Ticker
info
CTEV
Trading on
info
NYSE
ISIN
info
US62548M2098
Industry
info
Health Information Services
Sector
info
Healthcare
CEO
info
Travis S. Dalton
Headquarters
info
115 Fifth Avenue, New York, NY, United States, 10003
Employees
info
2,700
Website
info
claritev.com
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
Metrics
BasicAdvanced
Market cap
info
$705M
P/E ratio
info
-
EPS
info
-$72.90
Dividend Yield
info
0.00%
Beta
info
0.52
Forward P/E ratio
info
0
EBIDTA
info
$512M
Ex dividend date
info
-
Price & volume
Market cap
info
$705M
Average daily volume
info
0.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0.76
Price to book
info
47.35
Earnings
EPS
info
-$72.90
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$512M
Revenues (TTM)
info
$927M
Revenues per share (TTM)
info
$57.33
Technicals
Beta
info
0.52
52-week High
info
$74.07
52-week Low
info
$5.61
50-day moving average
info
$37.08
200-day moving average
info
$20.72
Short ratio
info
4.33
Short %
info
5.21%
Management effectiveness
ROE (TTM)
info
-198.69%
ROA (TTM)
info
0.83%
Profit margin
info
-126.96%
Gross profit margin
info
$688M
Operating margin
info
4.21%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-1.40%
Share stats
Outstanding Shares
info
16.4M
Float
info
5.6M
Insiders %
info
7.81%
Institutions %
info
82.25%
Analyst Insights & forecasts
info

50% Buy

50% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$34.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.89
-$0.06
-1,383.33%
Q2 • 24Missed
-$24.25
-$0.34
-7,032.35%
Q3 • 24Missed
-$8.53
-$0.33
-2,463.87%
Q4 • 24Missed
-$4.38
-$0.04
-10,850.00%
Q1 • 25Missed
-$3.81
-$2.00
-90.50%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$242M
$-62.6M
-25.93%
Q2 • 25
$246M
$-69.8M
-28.36%
Q3 • 25
1.82%
11.36%
9.37%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$5.07B
$5.11B
100.79%
Q2 • 25
$4.99B
$5.09B
102.04%
Q3 • 25
-1.61%
-0.39%
1.24%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$61.2M
$-24.6M
$-3.2M
$36.6M
Q2 • 25
$19.9M
$-22.9M
$-13.6M
$-16.3M
Q3 • 25
-67.57%
-7.12%
322.50%
-144.64%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Claritev Corporation share?
Collapse

Claritev Corporation shares are currently traded for undefined per share.

How many shares does Claritev Corporation have?
Collapse

Claritev Corporation currently has 16.4M shares.

Does Claritev Corporation pay dividends?
Collapse

No, Claritev Corporation doesn't pay dividends.

What is Claritev Corporation 52 week high?
Collapse

Claritev Corporation 52 week high is $74.07.

What is Claritev Corporation 52 week low?
Collapse

Claritev Corporation 52 week low is $5.61.

What is the 200-day moving average of Claritev Corporation?
Collapse

Claritev Corporation 200-day moving average is $20.72.

Who is Claritev Corporation CEO?
Collapse

The CEO of Claritev Corporation is Travis S. Dalton.

How many employees Claritev Corporation has?
Collapse

Claritev Corporation has 2,700 employees.

What is the market cap of Claritev Corporation?
Collapse

The market cap of Claritev Corporation is $705M.

What is the P/E of Claritev Corporation?
Collapse

The current P/E of Claritev Corporation is null.

What is the EPS of Claritev Corporation?
Collapse

The EPS of Claritev Corporation is -$72.90.

What is the PEG Ratio of Claritev Corporation?
Collapse

The PEG Ratio of Claritev Corporation is null.

What do analysts say about Claritev Corporation?
Collapse

According to the analysts Claritev Corporation is considered a buy.